Publication | Closed Access

Levetiracetam for levodopa-induced dyskinesia in Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

Psychotropic MedicationParkinson DiseaseLevodopa-induced DyskinesiaPharmacologyNeuropharmacologyPlacebo-controlled TrialPharmacotherapyNeurologyMedicineMovement Disorders